日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Direct Observation of Nanometer-Sized Steps of Single Myosin VI Molecules in Living Cells

直接观察活细胞中单个肌球蛋白VI分子的纳米级步进

Nguyen, Quang Quan; Zeng, Jiamin; Bui, Truong Son; Roßmann, Kilian; Yin, Yandong; Broichhagen, Johannes; Sweeney, H Lee; Park, Hyokeun

Functional and structural pathologies in skeletal muscle of a rat model of Duchenne muscular dystrophy

杜氏肌营养不良症大鼠模型骨骼肌的功能和结构病理

Lee, Young Il; Hart, Cora C; Henley-Beasley, C Spencer; Herr, Jeffrey S; Zerpa, Eli; Barton, Elisabeth R; Hammers, David W; Sweeney, H Lee

Development of clinically viable non-muscle myosin II small molecule inhibitors.

开发具有临床应用价值的非肌肉肌球蛋白 II 小分子抑制剂

Radnai Laszlo, Young Erica J, Kikuti Carlos, Toth Katalin, Zhou Minghai, Hafenbreidel Madalyn, Stremel Rebecca F, Lin Li, Pasetto Paolo, Jin Xiaomin, Patel Aagam, Conlon Michael, Briggs Sherri B, Heidsieck Leïla, Sweeney H Lee, Sellers James, Krieger-Burke Teresa, Martin William H, Sisco Jay, Young Steven, Pearson Paul, Rumbaugh Gavin, Araldi Gian Luca, Duddy Steven K, Cameron Michael D, Surman Matthew, Houdusse Anne, Griffin Patrick R, Kamenecka Theodore M, Miller Courtney A

Effect of Tadalafil on cardiac function and left ventricular dimensions in Duchenne muscular dystrophy: safety and cardiac MRI substudy results from a randomized, placebo-controlled trial

他达拉非对杜氏肌营养不良症患者心脏功能和左心室尺寸的影响:一项随机、安慰剂对照试验的安全性和心脏磁共振成像子研究结果

Cox, David; Byrne, Barry; Hammers, David W; Landry, John; Sweeney, H Lee

Dual S100A1 and ARC gene therapy as a treatment for DMD cardiomyopathy.

双重 S100A1 和 ARC 基因疗法治疗 DMD 心肌病

Hammers David W, Hart Cora C, Lee Young Il, Sleeper Margaret M, Sweeney H Lee

Spatiotemporal transcriptomic mapping of regenerative inflammation in skeletal muscle reveals a dynamic multilayered tissue architecture

骨骼肌再生性炎症的时空转录组图谱揭示了一种动态的多层组织结构

Patsalos, Andreas; Halasz, Laszlo; Oleksak, Darby; Wei, Xiaoyan; Nagy, Gergely; Tzerpos, Petros; Conrad, Thomas; Hammers, David W; Sweeney, H Lee; Nagy, Laszlo

Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response

杜氏肌营养不良症合并心肌病及线粒体疗法改善治疗反应的潜力

Gandhi, Shivam; Sweeney, H Lee; Hart, Cora C; Han, Renzhi; Perry, Christopher G R

Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophy

磁共振生物标志物变化对杜氏肌营养不良症的临床意义

Willcocks, Rebecca J; Barnard, Alison M; Daniels, Michael J; Forbes, Sean C; Triplett, William T; Brandsema, John F; Finanger, Erika L; Rooney, William D; Kim, Sarah; Wang, Dah-Jyuu; Lott, Donovan J; Senesac, Claudia R; Walter, Glenn A; Sweeney, H Lee; Vandenborne, Krista

Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies - Developing Potential Treatments for the Entire Spectrum of Disease

行业指南草案:杜氏肌营养不良症、贝克尔肌营养不良症及相关肌营养不良症——开发针对所有疾病谱的潜在疗法

McDonald, Craig; Camino, Eric; Escandon, Rafael; Finkel, Richard S; Fischer, Ryan; Flanigan, Kevin; Furlong, Pat; Juhasz, Rose; Martin, Ann S; Villa, Chet; Sweeney, H Lee

Myosin VI powers self-organization of branched contractile actin network

肌球蛋白VI驱动分支状收缩肌动蛋白网络的自组织

Höök, Peter; Lee, Young Il; Sweeney, H Lee